Poster Abstract Session:
118. Bone, Joint, and Soft Tissue Infection
Friday, October 19, 2012: 12:30 PM-2:00 PM
Room: SDCC Poster Hall F-H

Topical Category: A. Antimicrobial Agents and C. Clinical Studies

Tracks: Adult ID, Pediatric ID, Epidemiology and Infection Control

Presentations:

870
Acute Haematogenous Osteomyelitis in Children in The Era of Community Associated-Methicillin Resistant Staphylococcus aureus: A Retrospective Review
Dawood Yusef, MD ; Charles Foster, MD ; Lara Danziger-Isakov, MD ; Johanna Goldfarb, MD ; Sarah Worley, MS ; Camille Sabella, MD

871
Acute Renal Failure Associated with Vancomycin and Beta-lactams for the Treatment of Osteomyelitis: Piperacillin/Tazobactam Compared to Cefepime
Ryan P. Moenster, Pharm.D. ; Travis W. Linneman, Pharm.D. ; Patrick M. Finnegan, Pharm.D. ; Stephanie Hand ; Zaneta Thomas ; Jay McDonald, MD

872
Retrospective Review of Pyogenic Diskitis and Vertebral Osteomyelitis in a Large Urban Medical Center
Arash Poursina, MD ; Wajid Siddiqui, MD ; David Parker, PhD ; Shana Dykema ; Sharon Weissman, MD
Posters
  • PDVO.pdf (964.4 kB)

  • 873
    Use of Sonication for Diagnosis of Orthopedic Hardware Infection
    Samina Khumri, MD ; Lisa Clough, MD ; Rebecca Horvat, PhD ; Wissam El Atrouni, MD
    Posters
  • IDSA poster 8x4ver2.pdf (802.5 kB)

  • 874
    Diabetic foot ulcers and previous antibiotic use
    Fernando Del Fiol, PHD ; Maria Teresa Quilici

    875
    Daptomycin versus vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): A case-control study
    Stephen Liang, MD ; Hani Khair, MD ; Ellen Murray ; Hilary M. Babcock, MD, MPH ; Jonas Marschall, MD

    876
    Multidrug resistant gram negative rod (MDR GNR) infection hinders outcome improvements in severe infected necrotizing pancreatitis
    Erin Hanna, MD ; Catherine Passaretti, MD ; James Horton, MD ; Julie E. Williamson, PharmD ; John Martinie, MD ; David Iannitti, MD ; David Sindram, MD, PhD
    Posters
  • IDSA Poster.pdf (384.2 kB)

  • 877
    Disseminated Cutaneous and subcutaneous Rhinosporidiosis - a case series study from South India
    Teny Mathew John, MD, DNB ; Ceena Neena Jacob, M.D. ; Amith Jacob, M.B.B.S. ; Amrutha Mary George, M.B.B.S. ; Jerry Xavier, MBBS

    878
    Risk Factors for Clinical Failure in Outpatients Treated for Cellulitis and Cutaneous Abscess
    Elizabeth S. Zhu, Pharm.D. ; Jenana Halilovic, Pharm.D., BCPS ; Brett Heintz, PharmD, BCPS-ID, AAHIVE ; Cinda Christensen, PharmD, BCPS-ID

    881
    Pharmacokinetics and Pharmacodynamics of Oral Cephalexin in Children with Osteo-articular Infection
    Julie Autmizguine, MD ; Yves Théorêt, PhD ; Nastya Kassir ; Céline Laferrière, MD ; Stefan Parent, MD, PhD ; Bruce Tapiero, MD ; Philippe Ovetchkine, MD, MSc
    Posters
  • poster 881 PK_PD Cephalexin.pdf (358.8 kB)

  • 883
    Epidemiology and Clinical Outcomes associated with Community Acquired Complicated Intra-abdominal Infections caused by Extended-Spectrum-BetaLactamase-producing Enterobacteriaceae
    Yang Xie, PhD, MPH ; Vaishali Pawar, MPH, MBBS ; Girish D. Prajapati, M.B.B.S., MPH ; Dongmu Zhang, PhD ; Myrna Mendoza, MD ; Pattarachai Kiratisin, MD, PhD ; Po Ren Hseuh, MD ; Wen-Chien Ko, MD ; Elmano Ramalheira, MD ; Ana Paula Castro, MD ; Fernando Rosso, MD
    Posters
  • ID Week-FINAL.pdf (372.4 kB)

  • 884
    Immune Profiling of Early Lyme Disease
    Mark Soloski, PhD ; Manish Kumar, PhD ; George Wu, BS ; Hongkai Ji, PhD ; Kathleen Kortte, PhD, ABPP-CN/RP ; Lauren Crowder, MPH ; John Aucott, MD

    885
    Evidence Against the Psychological Vulnerability Hypothesis of Post-Treatment Lyme Disease Syndrome
    Kathleen Kortte, PhD, ABPP-CN/RP ; Lauren Crowder, MPH ; John Aucott, MD

    887
    A Pilot Study of Indigenous Cutaneous Microbes in Patients with Skin Abscesses
    James Horton, MD ; Guillermo Perez ; Zhan Gao ; Sullivan D. Matthew, MD ; Martin Blaser, MD, FIDSA

    CME Credits:


    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.